chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient had parked in the COVID vaccine waiting area, and was observed to fall forward onto his steering wheel within a few minutes of parking by 2 other participants waiting in the car next to him. One of them immediately notified one of the parking lot volunteers who came and got me within 1 minute of this observation. 2 students and I came quickly to the open drivers side door and began talking to assess the situation. Mr. Bannister appeared pale, mildly diaphoretic (sweating) and slightly confused as to the passage of time, but was able to state and spell his name and talk coherently about his circumstances. He stated that he was not allergic to anything that he knew about, and that he had no prior history of similar reactions to vaccines or medicines although he had not taken any shots in several years. He noted that he had not eaten anything since breakfast (now mid-afternoon). He described himself as initially feeling weak, faint, and nauseated with his vaccinated arm feeling heavy and numb. He also reported that he had a sensation of blurriness before passing out, but denied any spinning sensation, visual loss or ringing in the ears. There were no obviously visible abrasions or bleeding on his face or forehead. The nursing students brought a chair, and we elevated his legs and gave him some water to drink during the time we were monitoring his vital signs. He refused a cupcake because of the nausea, but as time progressed he gained facial color and was more comfortable in conversing. His hands had equal muscle grip and strength, visible fingernail beds were pink and his capillary refill was less than 3 seconds. Towards the end of our monitoring, he did accept some nuts and M & Ms to eat. A University Safety Medical Report was completed by the appropriate safety personnel. He was fully AAO x 3 at the end of our monitoring, and stated that if he felt better he would drive to his apartment (less than 5 minutes away) but would wait for his girlfriend to get out of class if he did not feel fully capable of driving. We encouraged him to eat something light when he got home, to use cool water/warm water soaks at his shot site, exercise his arm, and to take an NSAID for pain relief the next day. We recommended that he eat something light before his second shot (which had already been scheduled), that he bring someone with him the next time, and as a precaution to wait 30 minutes following the second shot. He left at 3: 15 pm driving his car without any apparent difficulties. An online report was completed for the incident 04/20/2021.
dry heaves; arm hurting; muscle pain; joint pain; fever; chills; nausea; Headache; A spontaneous report was received from a Other Health Professional concerning a 45-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and developed muscle pain, joint pain, fever, chills, arm hurting, nausea, dry heaves, and headache.   The patient's medical history, included positive COVID-19 test in Nov 2020. No relevant concomitant medications were reported.   On 28 Dec 2020, the patient received her first of two planned doses of mRNA-1273 (lot: unknown) intramuscularly for prophylaxis of COVID-19 infection.   28 Dec 2020 the patient experienced fever of 99.4 to 99.6 joint pain, muscle pain, and her skin hurt. The patient also experienced dry heaves, nausea, and headache.   At the time of the report on 07 Jan 2021 the events had resolved.  Treatment of the events included Tylenol every four hours.  Action taken with mRNA-1273 in response to the events was not provided .   The outcome of the events muscle pain, joint pain, fever, chills, arm hurting, nausea, dry heaves, and headache were recovered.  Reporter causality for the events was not provided.  Additional information received on 07 Jan 2021 included units for fever and date of outcome for the events.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
she has inflammation in her legs; leg burn; ankle swelling; her legs won't stop burning in her legs from her thighs down to her feet; she has arthritis, and her left leg is worse than her right leg and she has to use a cane and cannot stand.; This is a spontaneous report from a Pfizer-sponsored program.  A 59-years-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EP7534), via an unspecified route of administration on 27Mar2021 (At the age of 59 years) as DOSE 1, single, via an unspecified route of administration, patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: was not reported), administered in Arm Left on 17Apr2021 (At the age of 59 years) as DOSE 2, single, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced that her legs won't stop burning from her thighs down to her feet and there is tenderness and burning in her feet. Also she had Ankle swelling. Patient did not had any problems walking before that and went to the orthopedist and was told she had arthritis and her left leg was worse than her right leg and she had to use a cane and cannot stand. On 07Jun2021 they gave her the Cortisol steroids. Patient stated that she can't put pressure on her left leg and on 06Jul2021 had the steroid injection Cortisol and had that in both the right and left knee and they said it was inflammation and took x-rays and determined it was not a cartilage issue. Recently on 13Jun2021 went to the vascular HCP for the same thing and she had no blood clots in her legs but had a burning sensation in her legs. The patient underwent lab tests and procedures which included x-ray on unspecified date, X-rays showed inflammation. The outcome of the events were unknown.   No Follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Immediately following routine injection child developed approx. 5cm area of distinct localized hives at the injection site. 12.5mg p.o. BENADRYL & ice pack given with resolution of rash within approximately 30 mins after injection.
Temperature excursion administered up to 57 patients; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion administered up to 57 patients) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion administered up to 57 patients). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion administered up to 57 patients) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided. No treatment information was provided.
pt recv vax & pt devel a flare, splotchy red rash @ the inj site;pt recovered;
resident was given 0.3 ml of pfizer vaccine without being diluted with normal saline, resident received a concentrated dose of vaccine
3in x 3in lump at injection site, red in color and hot to touch; 3in x 3in lump at injection site, red in color and hot to touch; 3in x 3in lump at injection site, red in color and hot to touch; his arm remains very tender to touch; Lost sleep due to pain; This is a spontaneous report from a contactable other healthcare professional (patient). A 70-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot number: EJ1686, expiry date unknown) intramuscular at the left arm on 07Jan2021 at a single dose for COVID-19 immunization. The patient's medical history included COVID-19 prior to vaccination; HTN, High cholesterol, and Asthma, all from an unknown date. The patient is not pregnant. Concomitant medications included ASA, carvedilol, ferrous sulfate, losartan potassium, magnesium, rosuvastatin, calcium carbonate, colecalciferol (CALCIUM + VITAMIN D, pantoprazole sodium sesquihydrate (PROTONIX), budesonide, and formoterol fumarate (SYMBICORT). The patient had previous allergies with Zocor, Prolia, Evista, Daypro, Amlodipine, and Lisinopril. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2. Since the vaccination, the patient had not been tested for COVID-19. On 08Jan2021, 12:00 PM, the patient experienced 3in x 3in lump at the injection site, red in color and hot to touch. She lost sleep due to pain, his arm remains very tender to touch. No therapeutic measures were taken in response to the events. Outcome of the events at the time of last observation was recovering.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the events vaccination site mass, vaccination site erythema, vaccination site warmth and vaccination site pain cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
LIGHT HEADED; INABILITY TO CONCENTRATE; VERY SHORT OF BREATH; HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included: blood clotting disorder. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced light headed, inability to concentrate, very short of breath, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the light headed, headache, inability to concentrate and very short of breath was not reported. This report was non-serious.
Initial report was received 11 August 2010 from a health care professional which involved a cluster of eight patients who tested positive for pertussis. Patient identifiers were provided for seven patients; two who had previously received ADACEL (captured in case numbers 2010-04349 and 2010-04350); and three who had previously received an unspecified TdaP vaccine (captured in this case (2010-04353) and in case numbers 2010-04352 and 2010-04354), and two patients who had not received ADACEL, but had previously received a full DtaP vaccination series (captured in case numbers 2010-04351 and 2010-04376). At the time of the report, no information was available for the eight unidentified patient. A 12-year-old female patient had received an injection of TdaP on 28 May 2009 (manufacturer, lot number, route and site of administration not reported) and 432 days later on 03 August 2010, she was diagnosed with pertussis. Laboratory test results were positive for pertussis. Outcome was not reported, and no further information was provided at the time of the report. Documents held by sender: None.
Vaccine on December 29th, December 30th, woke up to find that on my fitness watch my heart rate reached over an hour of cardio and 2 minutes peak , over heart rate while sound asleep and 18 hours fat burn. With a broken ankle, I have been struggling before this incident to get my body in fat burning heart rate mode. The day before the vaccine, for example, I had no peak, no cardio, and only 7 hours of fat burn heart rate. So, this was a shocking increase, especially while sleeping.  Prior shot, I had severe fever of 103.5 so I waited a very long time before getting another vaccine.
Urticarial and macular, erythematous rash, joint swelling and tenderness.
I received my second Moderna booster for COVID-19 on 4/16/2022. On the morning of 7/9/2022, I developed a little bit of congestion and fatigue. This was a sudden development, so I wondered if I had COVID-19. I took two home tests that day, and they both yielded a positive result. As the day progressed, my symptoms worsened. I had fever, body aches, and head congestion. On 7/10/2022, I called to a NP who staffed the after hours phone number of the practice I go to, and she prescribed me a 5-day course of Paxlovid. She also suggested that I add Mucinex and Advil to my other to treat the symptoms. My symptoms worsened, because the congestion intensified and I developed a sore throat that felt like strep throat. It was so bad that I couldn't even sleep. On  7/12/2022, I had a telehealth meeting with my PCP at 10:30 AM. He suggested that, in addition to the other medications I was taking, I take Claritin during the day to treat the postnasal drip and resulting sore throat and Benadryl at night. I had no more fever after 7/13/2022, and the sore throat was much improved by 7/14/2022. Once I was able to sleep again, my symptoms really improved. At the time of this writing, I am still congested, so I am using Mucinex and Claritin to try to clear it up. Earlier this morning, I took another home test and got another positive result. Since I have a history of sinus issues and sinus infections, I am waiting to see if this results in a sinus infection that I will need to treat with antibiotics and Mucinex. However, I hope that I can avoid this by taking steps to clear out my sinuses first. I have also greatly increased my liquid intake.
The patient was in observation and complained of a sudden headache and left arm tingling.  The patient was assessed and the patient refused transport.  The patient signed out against medical advice.  See paramedic PCR for further detail.
Patient received 2nd dose of Pfizer COVID vaccine on 2/19/2021. Patient received COVID-19 PCR testing on 2/23/2021 for pre-surgical screening which resulted positive. He was asymptomatic at time of testing and remains asymptomatic as of submission of VAERS report. He reported a mild upper respiratory illness in early December with possible close contact to a patient with known COVID, but this patient was not tested for COVID-19 at that time. Member also received asymptomatic screening COVID-19 PCR test on 2/8/2021 which resulted negative/not detected.
24 hours the pain started around the injection site, it was warm, but to be expected.  A few hours later, my right arm was throbbing and preventing me from being comfortable and sleeping.  Around 2am, I tried to take one ibuprofen to reduce the pain so I could sleep.  It did work for a few hours, but the pain lingered off and one throughout the day.  3 days since the shot, the injection site is still warm, there is a small red dot, and the pain still runs from my fingertips to my shoulder, and across my shoulders and the base of my neck.  My Homeopath has informed me that I am having a reaction to the vaccine, and suggested I make this report.
Information has been received from a 72 year old male patient with no drug allergies and no medical history who on 10-JAN-2008 was vaccinated with ZOSTAVAX (Merck) (lot # not reported). Concomitant therapy included unspecified medications because the patient did not recall what he took. On 04-MAR-2011 the patient broke out with shingles. The patient had sought unspecified medical attention. Unspecified treatment was given to the patient. Lab diagnostics studies were not performed. At the time of reporting, the patient's outcome was unknown. Additional information has been requested.
leg paralized; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot number and expiry date was not reported) via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced leg paralized on an unspecified date. The outcome of the event was unknown.  Information regarding the lot/batch number has been requested.
Red rash  on both legs with purple pin point rash all over body with bruising. Low platelet count, low red blood cell count  Diagnosed with Vasculitis, Thrombocytopenia
febrile sz about 30hr p/vax;devel fever 18hrs p/shots
patient can not lift her left arm  (where she got shingles vaccine ) since day of vaccination.
Pain in upper arm where shot was administered. Some cracking sounds. Unable to sleep on left side or lift heavy objects. Movement of arm constrained.
Swelling, tenderness, and pain within 24 hours in left elbow joint with tenderness and pain, spreading to right elbow and forearm joint and tendons, right knee joint, left knee joint, and right hip. Tested positive for auto-immune RA. I had no problems, issues, symptoms, diagnosis, for RA prior to receiving the Covid  vaccine.
Had something as bad as herself or worse; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (had something as bad as herself or worse) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (had something as bad as herself or worse). At the time of the report, VACCINATION COMPLICATION (had something as bad as herself or worse) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided. Patient had a friend who had something as bad as herself or worse and that told her what to do.
Tightness in throat and jaw, tongue swelling, shortness of breath., chest pain Treatment at the ER with Benadryl and Pepcid
ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA 3/7/2023 &  3/6/2023  --  RECURRENCE OF SAME SYMPTOMS
Very painful at the sight of the injection which was hurting for a week. Feeling of anxiety and total body soreness. Swelling of the left knee where she couldn't bend at all. Swollen under the heel of her foot where she cannot walk. If she bend down she cant get back up.  Went to the doctor
POLYMYALGIA RHEUMATICA, SHOULDERS, HIPS AND KNEES.  INCREASE SYMPTOMS AT NIGHT. UNRESOLVED.
HEADACHE; This spontaneous report received from a patient concerned a 58 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, expiry: UNKNOWN) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 25-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache on 25-MAR-2021. This report was non-serious.
pt recv vax & pt was jerking, shaking & eyes rolling back;pt adm to hosp over noc for observation;mom reports that pt had fever noc a/vax given;
Patient reported he was not feeling well to this nurse, c/o pain in chest and felt like he was going to pass out.  Patient assisted to lay  down on floor by 3 staff, knees bent. Patient alert, pink, warm, dry, c/o dizziness and discomfort in chest.  Breathing unlabored, VS noted pulse 66,  O2 sats 97%, BP 143/81 left arm auto cuff.  Patient skin  assessed, no rash or hives noted, mask removed, lips and tongue normal shape and appearance. Patient denies any difficulty breathing. Reports feeling better laying down.  Patient reports not eating lunch today as he normally would.  Denies  diabetes or hypoglycemia issues. 1229 Pulse 62, 98% O2 sat on RA, BP 149/93 auto cuff lying down.  Patient assisted to sit up, denies dizziness, given granola bar and  6 oz apple juice to eat and drink. Patient reports feeling in his chest is gone while eating. Patient reports feeling better eating.  At 1233 BP 154/99 sitting with pulse of 69.  Patient assisted to stand, denies dizziness, BP 149/98 standing, pulse 73.  Patient denies dizziness or pain, states feels better.  Patient was d/cd walking with staff escorting and wheelchair at standby at 1238.  Reviewed patient's situation with caregiver and what to monitor for at home.
I was at a tournament sitting down and felt dizzy for 2 seconds. When I woke up I was lying on the floor. The paramedics told me my heart rate was down to 44. At the ER it was still down to 44. The DR didn't know what caused it, I didn't have a stroke or heart attack.  I have a follow up with my Cardiologist tomorrow.
10 days p/vax pt devel severe cough w/fever, difficulty breathing because of cough; tx ATB but pertussis not suspect @ time; sx cont & was sent to ER for throat cult; pos for pertussis organism; sibling had same sx; older
Swelling on and around site of reaction (left arm and left upper chest); fever, nausea; fatigue.
Itching, burning, fever, red in middle swollen, small bumps/blisters, wheezing. M.D. diagnosed as skin infection on 4/9/12 treated with heat compress, steroids, antibiotics.
Site was itchy immediately, around 24 hours later red, hot , swollen at injection site.
Within 24 hours a 3cm X 2 cm bulla filled with yellowish fluid developed at the vaccination site, with surrounding heat, erythema and pain. No systemic fever or chills. The bulla subsequently resorbed, but 10 weeks later, the patient has a residual area of erythema marking the base of the bulla's imprint.
Pt. developed redness and swelling on right thigh at injection site.  Warm compresses and Advil were prescribed.
Swelling, redness and pain to upper and lower left and right thigh, 3 1/2" diameter.
Once the pt sat in the chair she began putting tension on her muscle. I asked the pt several time to relax, I believe she was relaxed at the time of administer the pt again began place tension on the deltoid muscle, after retracting the vaccine needle the site started to swell. I then place a cold compression on the vaccine site and asked the on site physician to assets the site. The patient was place under observation for 20min and she reported feeling better and asked to leave.
pt recvd vax c/o vague abdo pain then nausea; pt turned grey 1" later, went totally limp w/in 1" later; checked by MD pulse steady resp adequate; color slowly returned in 15 mins; 10 mins p/fainting c/o joint pain h/a;